The Novo Holdings-owned biotech company Orexo has sold the rights in the US to its main asset, Zubsolv, for more USD 91 million
发布者:BY ALBERT RONNING-ANDERSSON,转转请注明出处:https://robotalks.cn/novo-company-headed-by-dane-lands-landmark-deal-in-the-us-its-with-mixed-feelings/